InVivo Therapeutics Debt To Equity vs. Total Debt

NVIVDelisted Stock  USD 1.38  0.07  5.34%   
Based on InVivo Therapeutics' profitability indicators, InVivo Therapeutics Holdings may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess InVivo Therapeutics' ability to earn profits and add value for shareholders.
For InVivo Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of InVivo Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well InVivo Therapeutics Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between InVivo Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of InVivo Therapeutics Holdings over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Please note, there is a significant difference between InVivo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if InVivo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InVivo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

InVivo Therapeutics Total Debt vs. Debt To Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining InVivo Therapeutics's current stock value. Our valuation model uses many indicators to compare InVivo Therapeutics value to that of its competitors to determine the firm's financial worth.
InVivo Therapeutics Holdings is rated below average in debt to equity category among its peers. It is rated below average in total debt category among its peers making up about  10,784,091  of Total Debt per Debt To Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value InVivo Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

InVivo Total Debt vs. Debt To Equity

Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

InVivo Therapeutics

D/E

 = 

Total Debt

Total Equity

 = 
0.09 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

InVivo Therapeutics

Total Debt

 = 

Bonds

+

Notes

 = 
949 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

InVivo Total Debt vs Competition

InVivo Therapeutics Holdings is rated below average in total debt category among its peers. Total debt of Health Care industry is now estimated at about 111.27 Million. InVivo Therapeutics maintains roughly 949,000 in total debt contributing less than 1% to equities under Health Care industry.
Total debt  Valuation  Workforce  Capitalization  Revenue

InVivo Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in InVivo Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, InVivo Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of InVivo Therapeutics' change in net profit over the period of time. It can combine multiple indicators of InVivo Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

InVivo Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on InVivo Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of InVivo Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the InVivo Therapeutics' important profitability drivers and their relationship over time.

Use InVivo Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InVivo Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InVivo Therapeutics will appreciate offsetting losses from the drop in the long position's value.

InVivo Therapeutics Pair Trading

InVivo Therapeutics Holdings Pair Trading Analysis

The ability to find closely correlated positions to InVivo Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InVivo Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InVivo Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InVivo Therapeutics Holdings to buy it.
The correlation of InVivo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InVivo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InVivo Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InVivo Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your InVivo Therapeutics position

In addition to having InVivo Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sector ETFs Thematic Idea Now

Sector ETFs
Sector ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 439 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in InVivo Stock

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity